HEATHER WILLETT: Open Payments
NPI 1649581190 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 17 payments from 12 companies in 2025. Trend: 2023 $1,262 · 2024 $151 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $86 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| BridgeBio Pharma, Inc. | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $34 |
| Abbott Laboratories | 1 | $25 |
| Medtronic, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Convatec Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: AMVUTTRA, VERQUVO, Attruby, LifeVest, PERCLOSE PROSTYLE, MICRA, Kerendia, FARXIGA.
Industry payments across IN — which companies pay providers there.
